Bladder cancer in the EMPA-REG OUTCOME trial

Diabetologia. 2017 Dec;60(12):2534-2535. doi: 10.1007/s00125-017-4430-0. Epub 2017 Sep 14.
No abstract available

Keywords: Bladder cancer; Cancer; Empagliflozin; SGLT2 inhibitors; Type 2 diabetes.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Glucosides
  • Humans
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2*
  • Urinary Bladder Neoplasms*

Substances

  • Glucosides
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2